|
|
||||||||



*
Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520;
Department of Biology, University of North Carolina, Charlotte, NC 28223; and
Center for Comparative Medicine, University of California, Davis, CA 95616
Spirochete adaptation in vivo is associated with preferential
Borrelia burgdorferi gene expression. In this paper, we
show that the administration of B. burgdorferi-immune
sera to IFN-
R-deficient mice that have been infected with B.
burgdorferi N40 for 4 days causes spirochete clearance. In
contrast, immune sera-mediated clearance of B.
burgdorferi N40 is not apparent in immunocompetent mice,
suggesting a role for IFN-
-mediated responses in B.
burgdorferi N40 host adaptation. B.
burgdorferi-immune sera also induces clearance of B.
burgdorferi N40 that have been passaged in vitro 75 times
(B. burgdorferi N40-75), a derivative of B.
burgdorferi N40 that does not rapidly adapt in vivo in
immunocompetent mice. B. burgdorferi N40-75 produce
lower levels of IFN-
and IL-12 in mice than does B.
burgdorferi N40, and the administration of these cytokines to
B. burgdorferi N40-75-infected mice results in an
increased spirochetal burden, further indicating that IFN-
-mediated
events promote B. burgdorferi survival. Differential
immunoscreening and RT-PCR demonstrate that IFN-
-mediated signals
facilitate spirochete recombination at the variable major
protein like sequence locus, a site for early antigenic
variation in vivo, and that recombination rates by B.
burgdorferi N40 are lower in IFN-
R-deficient mice than in
control animals. These results suggest that the murine immune response
can promote the in vivo adaptation of B.
burgdorferi.
This article has been cited by other articles:
![]() |
M. N. Hedrick, C. M. Olson Jr., D. B. Conze, T. C. Bates, M. Rincon, and J. Anguita Control of Borrelia burgdorferi-Specific CD4+-T-Cell Effector Function by Interleukin-12- and T-Cell Receptor-Induced p38 Mitogen-Activated Protein Kinase Activity. Infect. Immun., October 1, 2006; 74(10): 5713 - 5717. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim, J. Singvall, U. Schwarz-Linek, B. J. B. Johnson, J. R. Potts, and M. Hook BBK32, a Fibronectin Binding MSCRAMM from Borrelia burgdorferi, Contains a Disordered Region That Undergoes a Conformational Change on Ligand Binding J. Biol. Chem., October 1, 2004; 279(40): 41706 - 41714. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Crother, C. I. Champion, J. P. Whitelegge, R. Aguilera, X.-Y. Wu, D. R. Blanco, J. N. Miller, and M. A. Lovett Temporal Analysis of the Antigenic Composition of Borrelia burgdorferi during Infection in Rabbit Skin Infect. Immun., September 1, 2004; 72(9): 5063 - 5072. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liveris, V. Mulay, and I. Schwartz Functional Properties of Borrelia burgdorferi recA J. Bacteriol., April 15, 2004; 186(8): 2275 - 2280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Salazar, C. D. Pope, T. J. Sellati, H. M. Feder Jr, T. G. Kiely, K. R. Dardick, R. L. Buckman, M. W. Moore, M. J. Caimano, J. G. Pope, et al. Coevolution of Markers of Innate and Adaptive Immunity in Skin and Peripheral Blood of Patients with Erythema Migrans J. Immunol., September 1, 2003; 171(5): 2660 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Crowley and B. T. Huber Host-Adapted Borrelia burgdorferi in Mice Expresses OspA during Inflammation Infect. Immun., July 1, 2003; 71(7): 4003 - 4010. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Crother, C. I. Champion, X.-Y. Wu, D. R. Blanco, J. N. Miller, and M. A. Lovett Antigenic Composition of Borrelia burgdorferi during Infection of SCID Mice Infect. Immun., June 1, 2003; 71(6): 3419 - 3428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Anguita, S. W. Barthold, R. Persinski, M. N. Hedrick, C. A. Huy, R. J. Davis, R. A. Flavell, and E. Fikrig Murine Lyme Arthritis Development Mediated by p38 Mitogen-Activated Protein Kinase Activity J. Immunol., June 15, 2002; 168(12): 6352 - 6357. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |